Cipla will make AIDS drug for kids

HYDERABAD: Generics major Cipla Ltd will manufacture the first three-in-one cocktail anti-AIDS drug meant for children.

The problem is massive and children have been by far ignored till now as there were no right dosages available for supply,” Amar Lulla, managing director, Cipla, said.

This is the first pediatric dosage of the combination and given that only 50,000 children are under treatment currently, the goal is to reach 10 times the number, he told DNA Money.

The Pepfar programme is unique in the sense generics makers such as Cipla can make still-under-patent drugs for supply to countries mostly in sub-Saharan Africa, which are the worst affected by HIV/AIDS at highly subsdised prices.read more